i3

inVentiv expands services to Korea

Thursday, November 10, 2011 09:28 AM

inVentiv Health has established inVentiv Health Korea, a Seoul-based operation that will provide clinical development and commercial services to healthcare clients.

More... »

Carlyle Partners, Hellman & Friedman to acquire PPD for $3.9 billion, take the CRO private

Monday, October 10, 2011 08:02 AM

It’s official: Large equity investors Carlyle Partners and Hellman & Friedman Capital Partners are buying publicly traded PPD, taking the CRO private.

More... »

PPD names CEO, puts acquisition rumors in question

Monday, September 26, 2011 08:02 AM

PPD has named a new CEO, a move that strikes some in the industry as a little strange in the face of rumors that the publicly traded CRO is close to selling itself to a private equity firm.

More... »

DeBoer joins Advanced Clinical

Tuesday, September 13, 2011 11:59 AM

Advanced Clinical has reported that Ami DeBoer has joined the company as director of recruiting. As director of recruiting, DeBoer is responsible for recruitment operations and managing Advanced Clinical’s Midwest and East Coast recruiting teams. She is also responsible for full life-cycle recruitment, executing on contract and direct hire search assignments for the company's clients.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

inVentiv Health completes i3 acquisition

Monday, June 13, 2011 09:56 AM

inVentiv Health has completed the acquisition of CRO i3. i3, previously owned by Ingenix, a UnitedHealth Group company.

More... »

CRO consolidation craze continues as inVentiv scoops up PharmaNet, propelling it into top tier

Monday, May 23, 2011 08:40 AM

The Pac Man game continues, with mid-tier CROs being acquired or buying one another on an almost weekly basis.

More... »

Kendle names Dr. Martha Feller vice president

Wednesday, March 9, 2011 11:00 AM

CRO Kendle has named Martha R. Feller, Ph.D., vice president and global head of study start-up. Dr. Feller brings to Kendle more than 30 years of senior operations leadership in the clinical development industry, including therapeutic expertise and experience in managing global development programs. She will provide leadership for Kendle's global study start-up function, including management, site identification, regulatory, investigator contracts and essential document collection. 

More... »

inVentiv Health buys i3 divisions, Campbell Alliance, allowing it to compete with CRO industry’s big players

Monday, January 31, 2011 08:00 AM

Ingenix, a UnitedHealth Group subsidiary that provides health care information to the managed care and drug development sectors, is selling off its clinical trial management and contract research services. Those holdings include i3 Research, i3 Statprobe and i3 Pharma Resourcing. 

More... »

More big pharmaceuticals join trend of partnering with CROs to cut costs, speed drug development

Monday, October 11, 2010 10:27 AM

Major pharmaceutical companies are increasingly forming long-term, strategic partnerships with a small number of global contract research organizations (CROs) in order to cut costs and streamline their outsourced clinical work.

More... »